UnknownPhase 3

Safety and Efficacy of the Effect of Isosorbide Mononitrate in Reducing Pain During Levonorgestrel-releasing Intrauterine Device Insertion

88 participantsStarted 2020-03-30

Plain-language summary

the aim of the study is to evaluate the safety and efficacy of isosorbide mononitrate vaginal administration in reducing pain during LNG-IUD insertion in adolescents and young women

Who can participate

Age range14 Years – 25 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * adolescents and young women requesting LNG-IUD insertion Exclusion Criteria: * heavy vaginal bleeding,pregnancy, contraindications to IUD insertion, allergy or contraindication to isosorbide mononitrate, uterine anomaly

What they're measuring

pain during IUD insertion

Timeframe: 5 minutes

Trial details

NCT IDNCT04311658

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-06-25

Contact for this trial

AHMED SAMY

+201100681167 ahmedsamy8233@gmail.com

View on ClinicalTrials.gov More Contraception trials